Unigene Laboratories, Inc.

Industry

  • Biotechnology
    • Large Molecule
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
      • Macromolecule
    • Nutraceuticals
See more in Biomedtracker

Latest on Unigene Laboratories, Inc.

Pink Sheet

FDA Keeps Calcitonin Products On The Market But Narrows Osteoporosis Claim

 
• By Sue Sutter

FDA is again using its other regulatory options to avoid withdrawing marketing approval, keeping calcitonin-salmon products on the market with a narrowed indication and new warning language about pote

Pink Sheet

Deals of the Week: Is Astex Settling For An Underpriced Buyout?

 
• By Paul Bonanos, Lisa LaMotta, and John Davis

A month after Otsuka Pharmaceutical Co. Ltd. agreed to buy cancer drug developer Astex Pharmaceuticals Inc. for $886 million, a top shareholder is challenging the deal. Sarissa Capital Managem

Pink Sheet

Enteris Begins Its Phoenix Story With Nordic Deal

 
• By Lisa LaMotta

Just three months out of the gate, Enteris BioPharma Inc. has signed its first licensing deal; shedding the shadow of its previous incarnation and moving into a future with more opportunity. “This

Scrip

Fish or cut bait: Nix calcitonin salmon osteoporosis use, FDA panel advises

 
• By Donna Young

A majority of US FDA advisers on 5 March said the agency should no longer allow calcitonin salmon to be marketed as a treatment for postmenopausal osteoporosis (PMO) – voting 12-9 the overall risk-ben